Surgical Pathology Criteria

Thymic Carcinoma

Supplemental Studies

Immunohistology

Epithelial cell staining (thymocytes and T cells are CD5 positive)
  CD5 CD117 CD57
Thymoma (except B3) neg 4% pos
B3 Thymoma / Atypical Thymoma 50% <10% pos
Thymic Carcinoma 70-100% >80% rare

 

Stanford Medicine Resources:

Footer Links: